Abbott (NYSE:ABT) CEO Miles White may have chosen an eventual successor to take over the corner office, according to a new Forbes report. White, who has been at the head of Abbott for 20 years, named long-time exec Robert Ford as the company’s president and COO, according to the report.The appointment marks the first time an […]
Stryker extends deadline on $1.4B K2M buy as shareholders sue
Stryker (NYSE:SYK) yesterday filed to extend the anti-trust deadline on its $1.4 billion acquisition of K2M (NSDQ:KTWO) to give the U.S. Federal Trade Commission more time to examine the deal, as shareholders filed suit to block the merger, K2M said today. The new FTC filing pushes the anti-monopoly waiting period out to Nov. 16, the Leesburg, Va.-based spinal […]
FDA deals warning letter to Ocular over eye sealant
Ocular Therapeutix (NSDQ:OCUL) said today that it received a warning letter from the FDA over its ReSure hydrogel ocular wound sealant. The warning letter, dated Oct. 17, relates to Ocular’s compliance with data collection and reporting obligations in a post-approval device exposure registry study, according to the company. The registry study was a condition for approval […]
Intuitive Surgical jumps on Q3 beats, increased procedures outlook
Shares of Intuitive Surgical (NSDQ:ISRG) got a pre-market bump today after the robot-assisted surgery pioneer posted third-quarter results that beat the consensus forecast, despite lower profits, and upped its outlook on procedure growth for the year. Sunnyvale, Calif.-based Intuitive posted profits of $292.5 million, or $2.45 per share, on sales of $920.9 million for the three […]
TransEnterix CEO Pope makes Time’s 50 Most Influential People in Healthcare
TransEnterix (NYSE:TRXC) said today that its president and CEO Todd Pope has been named to Time Magazine’s Most Influential People in Health Care for 2018, highlighted for their work bringing the Senhance robotic surgical platform to the market. Pope was an inaugural selection for the list, which Time Magazine said it assembled to highlight “physicians, scientists, and […]
Abbott alleges ex-marketing exec lifted its neuromod marketing playbook
Abbott (NYSE:ABT) this week accused a former marketing executive of purloining the marketing playbook for its neuromodulation business on his way out the door to a marketing job at competitor Nevro Corp. (NYSE:NVRO). In a lawsuit filed in the U.S. District Court for Northern Illinois, Abbott alleged that former neuromodulation global marketing product manager Blayne […]
Getinge’s Atrium Medical deals biosurg biz to SeCQure Surgical parent
Getinge (PINK:GETI B) subsidiary Atrium Medical said today that it agreed to deal its biosurgery business to the parent company of SeCQure Surgical for an undisclosed amount. Göteborg, Sweden-based Getinge acquired the biosurgery unit, which makes soft tissue reinforcement devices, in the $680 million deal for Atrium back in 2011. Today Getinge said it agreed to sell the business, which […]
Report: Nevada’s Heller pushed unapproved TMS treatment on VA
Nevada Senator Dean Heller (R-NV) encouraged doctors at a Reno-based Veterans Affairs medical center to use an off-label transcranial magnetic stimulation technology marketed by a company with connections to his office, according to a new ProPublica report. The company, called CereCare, markets a technology it says uses electrical scans of the brain and heart to […]
Dexcom wins CMS nod for latest glucose monitor
Dexcom (NSDQ:DXCM) said today that its G6 continuous glucose monitoring system will be covered for Medicare beneficiaries. The company’s product won coverage as a therapeutic CGM system, making it available to beneficiaries who closely manage their insulin dosing. Get the full story at our sister site, Drug Delivery Business News.
Evolent Health prices $150m convertible debt offering
Evolent Health (NYSE:EVH) yesterday priced an upcoming $150 million convertible debt offering. The Arlington, Va.-based company said it plans to offer 1.5% convertible senior notes due 2025 in the offering, with a 30-day option to initial purchasers to acquire an additional $22.5 million aggregate principal amount of notes. Interest on the notes is payable semiannually in […]
Abbott CEO on Libre: ‘We’re just getting started’
Abbott (NYSE:ABT) posted its third quarter financial results yesterday, meeting its own forecast and the consensus set by analysts on Wall Street. The healthcare giant also narrowed its earnings outlook for the rest of the year. Abbott noted particularly high gains in revenue for its medical device division – sales were up 8.4% to $2.82 billion, in part […]
- 1
- 2
- 3
- …
- 14
- Next Page »
MassDevice Network
@MassDevice
LinkedIn